SciELO - Scientific Electronic Library Online

vol.30 issue3Identification of genes with altered expression levels in contrasting rice cultivars exposed to salt stress treatmentsExpression and purification of a full-length recombinant NS1 protein from a dengue 2 serotype viral isolate author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Biotecnología Aplicada

On-line version ISSN 1027-2852


AGUILERA, Ana et al. Formulation development of a recombinant Streptokinase suppository for hemorrhoids treatment. Biotecnol Apl [online]. 2013, vol.30, n.3, pp.182-186. ISSN 1027-2852.

Recombinant Streptokinase (rSK) is a protein of bacterial origin currently used in the treatment of acute myocardial infarction. Its thrombolytic and anti-inflammatory action makes it attractive for the treatment of hemorrhoids. In this work the influence of absorption enhancer, preservative and emulsifiers on rSK stability was accessed by determining its biological activity under stress conditions. According to the results obtained, were selected as excipients for the formulation: Sodium salicylate as enhancer and anti-inflammatory agent, thimerosal as preservative, Span 60 as emulsifier and Witepsol W25 as suppository base and 100 000 IU per gram of suppository for stability study. Afterwards, three lots at pilot scale were manufactured, packed in aluminum blister shell and stored at 5 ± 3 ºC. Immediately after preparation, the samples were evaluated at months 0, 3, 6, 9, 12 and 18 having into account the physical, chemical and biological properties. The stability study demonstrated that the formulation containing rSK as active pharmaceutical ingredient was stable during 18 months under refrigerated conditions.

Keywords : streptokinase; suppository; hemorrhoids; formulations development; rectal administration; thrombolytic; long term stability.

        · abstract in Spanish     · text in English     · English ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License